课题基金 / 基金详情

Repair of Genome Destabilizing DNA Structures

Repair of Genome Destabilizing DNA Structures
修复基因组不稳定的 DNA 结构
批准号:
8989520
负责人:
Karen M Vasquez
金额:
$30.82万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-01-28 至 2017-12-31

项目摘要

项目成果

Karen M Vasquez的其他基金

相似基金

相关文献

中文摘要
翻译
描述(申请人提供):已知易位与许多癌症的病因有关,而DNA双链断裂(DSB)是许多致癌易位形成的重要第一步。然而,在对癌基因断裂“热点”处DSB产生机制的理解上存在着根本性的差距。例如,染色体断裂经常发生在基因组“热点”,并可能导致易位相关疾病。有趣的是,染色体断裂点“热点”经常被定位在能够采用交替结构DNA(即非B DNA,如H-DNA和Z-DNA)的重复DNA序列附近,这意味着这些结构与癌症病因学有关。申请人的实验室发现,自然产生的Z-DNA(在bcl-2的断点“热点”处发现)和H-DNA(在c-myc的易位断点“热点”附近发现)具有高度的突变性,并可在哺乳动物细胞和小鼠中诱导DSB,这为下一步检验新假设的基本原理提供了基础:1)非B DNA结构被认为是“损伤”的,并由DNA修复蛋白处理;2)非B DNA对导致DSB的DNA和RNA聚合酶具有阻断作用;3)非B DNA诱导的哺乳动物遗传不稳定性随着年龄的增长而增加,这与易位相关的癌症病因有关。这一新应用的长期目标是确定癌症病因学中DNA结构诱导的遗传不稳定性的机制,阐明与癌症相关的易位所涉及的机制,并开发减少遗传不稳定性以预防和/或治疗癌症的新方法。这一应用的直接目标是阐明与癌症相关的c-myc和bcl2基因的染色体断裂机制,并确定DNA修复、复制和转录在DNA结构诱导的基因组不稳定中的作用。为了实现我们的目标,我们将使用人类细胞和新的突变报告鼠来实现以下目的:1)确定DNA修复途径在癌症相关c-myc和bcl2基因中发现的非B DNA突变潜力中的作用;2)阐明人类细胞中非B DNA结构的复制无关和复制依赖的加工机制;3)评估转录对非B DNA诱导的人类细胞遗传不稳定性的影响;4)评价衰老对转基因小鼠组织中人c-myc和bcl2基因非BDNA形成序列诱变潜能的影响。这项拟议的工作具有创新性,因为它将检验新的假设,即DNA结构在本身没有DNA损伤的情况下,由修复机制识别和处理,并且这些结构涉及癌症病因学。这项拟议的研究的预期贡献是阐明癌基因中染色体断裂的机制,以更好地了解癌症病因,这一点具有重要意义,因为这一结果将有助于开发新的策略,帮助降低癌症发病率。
英文摘要
DESCRIPTION (provided by applicant): Translocations are known to be involved in the etiology of many cancers, and DNA double-strand breaks (DSBs) are an essential first step in the formation of many oncogenic translocations. However, there is a fundamental gap in understanding the mechanisms involved in the generation of DSBs at breakage "hotspots" in oncogenes. For example, chromosomal breakages frequently occur at genomic "hotspots" and can result in translocation-related disease. Interestingly, chromosomal breakpoint "hotspots" are often mapped near repetitive DNA sequences capable of adopting alternatively structured DNA (i.e., non-B DNA, such as H-DNA and Z-DNA), implicating these structures in cancer etiology. The discoveries from the applicant's laboratory that naturally occurring Z-DNA (found at a breakpoint "hotpspot" in BCL-2) and H-DNA (found near a translocation breakpoint "hotspot" in c-MYC) are highly mutagenic and can induce DSBs in mammalian cells and in mice, provide the basis for the rationale going forward to test the novel hypotheses that: 1) non-B DNA structures are recognized as "damage" and are processed by DNA repair proteins; 2) non-B DNA presents a block to DNA and RNA polymerases resulting in DSBs; and 3) non-B DNA-induced genetic instability increases with age in mammals, relevant to translocation-related cancer etiology. The long-term goals of this renewal application are to determine the mechanisms of DNA structure-induced genetic instability in cancer etiology, elucidate the mechanisms involved in cancer-associated translocations, and develop novel approaches to reduce genetic instability to prevent and/or treat cancer. The immediate objectives of this application are to elucidate the mechanisms of chromosomal breakage in the cancer-related c-MYC and BCL-2 genes, and to determine the roles of DNA repair, replication, and transcription in DNA structure-induced genomic instability. To accomplish our goal, we will use human cells and novel mutation-reporter mice in the following aims: 1) determine the roles of DNA repair pathways in the mutagenic potential of non-B DNA found in the cancer- related c-MYC and BCL-2 genes; 2) elucidate the mechanisms of replication-independent and replication- dependent processing of non-B DNA structures in human cells; 3) assess the effects of transcription on non-B DNA-induced genetic instability in human cells; and 4) evaluate the effects of aging on the mutagenic potential of non-B DNA-forming sequences from the human c-MYC and BCL-2 genes in tissues of transgenic mice. The proposed work is innovative because it will test the novel hypothesis that DNA structure, in the absence of DNA damage per se, is recognized and processed by the repair machinery, and that these structures are involved in cancer etiology. The expected contribution of the proposed research is to elucidate the mechanisms of chromosomal breakage in oncogenes to better understand cancer etiology, which is significant because the results will aid in the development of new strategies to help reduce cancer incidence.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Project 2: Error-free and Mutagenic Processing of Crosslinks
Impact of Short Inverted Repeats on Genetic Instability at Mutation Hotspots
  • 批准号:
    8756978
  • 项目类别:
  • 资助金额:
    $7.73万
  • 财政年份:
    2014
  • 负责人:
    Karen M Vasquez
  • 依托单位:
Impact of Short Inverted Repeats on Genetic Instability at Mutation Hotspots
  • 批准号:
    8889235
  • 项目类别:
  • 资助金额:
    $7.73万
  • 财政年份:
    2014
  • 负责人:
    Karen M Vasquez
  • 依托单位:
2012 DNA Damage, Mutation & Cancer GRC
  • 批准号:
    8249703
  • 项目类别:
  • 资助金额:
    $0.6万
  • 财政年份:
    2012
  • 负责人:
    Karen M Vasquez
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: